We look forward to connecting with the global energy investors and professionals attending Dearborn’s conference this week and to expanding awareness of our unique process
Houston, TX (PRWEB) April 07, 2014
Propell Technologies Group (OTCQB:PROP), the exclusive US licensee of Plasma Pulse technology for enhanced oil recovery (EOR) today announced the Company will be presenting to investors (presentation) and conducting Q&A at 3pm Monday April 7th, 2014 at the Dearborn NY Investor Forum, held at the Westin Times Square, 270 West 43rd St., New York.
Patent pending, Plasma Pulse is an advanced oil and gas well treatment that applies a down hole controlled arc discharge designed to create elastic waves that clear a well's perforation zone, stimulate mobility in surrounding pay zone and improve production in enhanced oil recovery (EOR) efforts.
Propell Technologies (PROP) has exclusively licensed the US rights and has commenced commercialization with treatments over the last 9 months of dozens of US wells. Click here for US well treatment results.
Partially funded by the Skolkovo Foundation and deployed in Russia, Kazakhstan, China and Eastern Europe for years, the tool is being re-engineered with delivery expected Q2, to improve treatment costs and expand its US market with improved compatibility with US wire configurations and well diameters.
“We look forward to connecting with the global energy investors and professionals attending Dearborn’s conference this week and to expanding awareness of our unique process,” stated John Huemoeller II, chief executive officer.
The Company invites attendees to review the above links to its investor presentation and join it Monday, April 7 at 3pm.
ABOUT PROPELL TECHNOLOGIES GROUP
Propell Technologies Group, Inc. (http://www.propell.com/), through its wholly owned subsidiary Novas Energy USA, is the exclusive U.S licensee of the Plasma Pulse enhanced oil recovery (EOR) well treatment that is designed to improve production cost effectively and without acidization, hydrofracking or other chemicals. It develops and commercializes treatment and stimulation of oil wells constructed to meaningfully improve production and enhance the recovery of oil and gas in existing wells.
This press release includes forward-looking statements of our current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as “may," “should," “potential," “continue," “expects," “anticipates," “intends," “plans," “believes," and similar expressions. These statements are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict and include statements regarding the results derived from use of our technology. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in our forward-looking statements include, among others, our ability to re-engineer the tool the other factors described in our on Form 10-K for the year ended December 31, 2012, and any other filings we may make with the SEC. The information in this press release is provided only as of the date written, and we undertake no obligation to update any forward-looking statements contained in this press release on account of new information, future events, or otherwise, except as required by law.